TMCnet News
Proteus Digital Health Adds Former Executives from Novartis, Microsoft and Egreetings Network to Team [Health & Beauty Close - Up](Health & Beauty Close - Up Via Acquire Media NewsEdge) Proteus Digital Health, a digital medicines company, announced the expansion of the company's executive team and board of directors with the addition of three new hires across consumer technology and global pharmaceuticals. "These three professionals bring decades of strategic, commercial and financial experience to Proteus, and have a deep understanding of what is required to bring important new products to market," said Andrew Thompson, CEO of Proteus Digital Health. "With their support, we will deliver empowering digital health products to individuals and their families." According to a release, Charles Songhurst has been appointed to the Proteus Digital Health Board of Directors, bringing significant investment and technology expertise to the company. Songhurst is Founding Partner at Katana Capital, an equity hedge fund. Previously, Songhurst ran Corporate Strategy for Microsoft and focused on partnering and M&A. "The digital revolution is transforming markets and industries across the world," said Songhurst. "We are seeing Silicon Valley style software and hardware innovation coming to healthcare which will increase the pace of innovation." Dr. Markus Christen joins Proteus as SVP and Head of Global Development, driving creation of the company's digital medicines portfolio. Dr. Christen served as the Global Head of Strategy, Business Development and M&A for Molecular Diagnostics and eHealth at Novartis Pharma AG where he led a project management portfolio in autoimmune diseases and transplantation. "Healthcare is changing rapidly," said Christen. "The need to demonstrate real patient outcomes from digital medicines is a significant global opportunity. I look forward to contributing to the great progress that Proteus has already made." Tony Levitan joins as SVP of People, and is focused on ensuring that the human aspects of the company continue to be as impressive as the intellectual property and new products. Levitan previously founded three companies, including Egreetings Network (IPO), an early Internet innovator that created the widespread digital greetings market. "Preeminence in digital medicine is a compelling and attractive mission for both our current and in-coming wave of Proteans," said Levitan. "The irresistible challenge is how to establish substantial market advantage through the People group's focus on integrating talent across semiconductors, pharmaceuticals, medical devices, big data, software and mobile. No other company combines what we do at Proteus." More Information: proteus.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |